PhD, Biochemistry
University of North Carolina at Chapel Hill, Chapel Hill, NC
BS, Biochemistry
Lehigh University, Bethlehem, PA
Gabrielle Dardis collaborates with researchers across therapeutic areas and research types to plan and develop clear, impactful publications. She has HEOR and patient-centered publications experience in oncology and CNS/neurology and neurodegenerative diseases, and research experience in oncology. Prior to joining RTI-HS, Dr. Dardis researched oncogenic crosstalk between epigenetic and inflammatory signaling pathways specific to triple negative breast cancer during her thesis work at the University of North Carolina at Chapel Hill (UNC). She has also researched nonapoptotic cell death pathways in triple negative breast cancer during a laboratory rotation at UNC, metabolic pathway targeting in osteosarcoma cells during internships at the Penn State University Cancer Institute, and joint development in the zebrafish tailfin during her undergraduate career at Lehigh University.